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not present. Rest and dobutamine flows in r@ons witbout >5&% 
diameter stenosis weeke 0.93 c 020 (mean 2 SD? and 2.16 2 
0.52 m%nin per g {p < WA), respectiveIy. The corresponding 
18ows in regions witbout a defect were 0,941 C 021 and 2.17 f 
0.53 ml/mia per g ia < O.Ol), respectively. ‘This t.+fotd iamase in 
flow was significantly co~Med (p C W&l) with a k&fold 
increase in rate-pmsure product induced by dobutamine, The 
rest ad dobutamine flsws for regions subtended by a vessel with 
>so% diameter stmosis were Qxs -c 833 arId 1,243 i 054 mlimin 
per g (p < (3.05), respectively, whereas the corresponding values 
for regioffs w%h a doktamine flowdef& were tI.69 i: CL.33 ml/min 
per g at rest and 1.23 + 0.54 mUmin per g during do&tam& {p < 
0.05). ISobutamiae iiweased How inverseEy proportioT.‘J1 :a per- 
cent diameter stenosis. The rest flow for regions wit5 a do&t- 
amine flow dedect were not significantiy d~~e~ut fkom that in 
qiom without defects. 
Co&uGoczs, Dobpatamine resulted in a siguiticant increase- in 
myocardiaf blond P.rprr that correlated significant@ wi~b both 
increased cardiac work and degree of stenosis. 
patients unable to adequate& pti$-form exercise stress tesfkg. 
Dabutamine is a synthetic sympa!homtietic amine that simu- 
lates exercise. Cardiac work axid coronary blood fiow are 
increased due to an increase in heart rate and contract&y. 
Dobatamine has been shown to increaw myocardial bloori i?ow 
in proportlm to the rafe-pressure product in normal voolzr?- 
teers (1). The vasod&wrs adenosine and dip~yridamole do not 
primarily increase cardiac work: rather? they increase coronar); 
ftow because of 3 direcf vasodiktor effect OR vascular smooth 
muscle. Stress, testing has been combinei’i :Gfh schocardio- 
graphic aad perfusion imaging techniques to enhance. the 
smsitiviry and specifiiify of dkgnosing coroo-axy arf~ry disease, 
as well YE to guide future therapy aafl provide progwkc 
information. 
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myocardial blood flow has been accomplished using 
nitrogen-13 (N-13) ammonia as a flow tracer in normal volun- 
teers at rest and during exercise (9), dobutamine (l), dipyrid- 
amole (10,lZ) aild adenosine (11). Rest myocardial blood flows 
have also been reported using N-13 ammonia in patients with 
a recent myocardial infarction (12). Oxygen-15 (0-IS)-labeled 
water has been used to mensure myocardial blood flow at rest 
and with dipyridamole (13-17). Adenosine and dipyridamole 
produce greater increases in myocardial blood flow than either 
exercise or dobutamine (1,9-11,13-17). This is because aden- 
osine and dipyridamole are direct vasodilators and result in 
maximal myocardial perfusion regardless of demand. Exercise 
and dobutamine, in contrast, increase myocardial blood -Row by 
directly increasing the cardiac work toad, which usually does 
not result in maximal vasodilation. 
Dobutamine is favored by many over the direct vasodilators 
for pharmacologic stress testing because it more closely simu- 
lates exercise. In the current investigation, we studied patients, 
who had coronary arteriographic data, with positron emission 
tomography and high dose dobutamine stress testing. 
Nitrogen-13 ammonia was used as a flow tracer at rest and with 
dobutamine. The goal was to measure the effect of dobutamine 
on myocardial blood flow and to determine the correlations 
among myocardial blood flow, cardiac work and degree of 
coronav artery stenosis. 
Patients. The study group included 15 patients (mean 
[“SD] age 62 + 12 years, range 39 to 80; 13 men, 2 women) 
who had undergone coronary arteriography for known or 
snspected coronary artery disease. Written informed consent, 
approved by the University of California Los Angeles Human 
Subject’s Committee, was obtained fror;a each patient. Four 
patients had a previous documented m~~ocardial infarction. 
The clinical characteristics of the patients are shown in Table 
1. Subjects were studied in the nonfastini:, state. 
Image asquisition. Patients were positioned in a whole- 
body tomograph (mode! 931, CT~Siern en:, Gamilasonics) that 
simultaneously acquires 15 transvesse skt;s. The axial field of 
view is 10.8 cm. and the slices are spaced 6.8 mm apart. The 
spatial resolution was -10 mm full width half maximum in 
plane and -7 mm in the axial projections, A rectilinear 
transmission scan was initially obtained to aid in patient 
positioning within the tomograph. Transmission imaging was 
performed to correct for photon aitemation. 
Study protoroi. EXh patient received an injection of 
15 mCE of N-13 ammonia, delivered by continuous C&&n 
over 30 s, at rest and -1 h later dur‘ing peak dobutamine 
infusion. Dynamic imaging commenced with rhe onset of each 
injectiotr. Twelve X0-s inmges, &.VJ 60-s images and otte 9#1-s 
intdge were obtained. 
were recorded at rest and every 1 to 3 min during the 
dobutamine infusion. Heart rate and rhythm were continu- 
ously monitored. Dobutamine was discontinued if the patient 
developed one of the following symptoms or findings: moder- 
ately severe angina or dyspnea, >2-mm ischemic ST segment 
depression, frequent ventricular ectopic activity (e.g., short 
runs of ventricular tachycardia or >5 premature ventricular 
contractions/~&), decrease in blood pressure below baseline, 
nausea or other uncomfortable side effects of dobutamine, 
such as flushing or agitation. Nitrogen-13 ammonia was in- 
jected at the peak tolerated dose of dobutamine or at 40 &kg 
per min (after it was determined that there were no further 
increases in heart rate or blood pressure at the 40 @kg per 
mio dose). Dobutamine was discontinued 3 min after injection 
of N-13 ammonia, except in two patients who required discon- 
tinuation of dobutamine immediately after the N-13 ammonia 
injection because of nausea in ose patient and slow ventricular 
tachycardia in another. 
Image analysis: polar maps and comparison with normal 
data base. Transaxial images were reoriented inro left ventric- 
ular short-axis views using a computeT software program 
developed and previously validated in our laboratory (18J9). 
The reoriented images were d&i-’ J L+ “eu Iliro six short-axis planes. 
The true apex of the heart was not inciuded in the six planes. 
Polar maps were generated from the last dynamic image 
using circumferential profiles of the madmal regional myocar- 
dial count activity obtained along 60 equally spaced radians. 
Assuming that normal myocardium will exhibit the highest flow 
rates> the rest and dobQtamine N-13 ammonia polar maps were 
then normalized using an average of the top 5% of ihe N-!3 
ammonia raw counts for each study to obtain a normalization 
factor for each study. Data were considered within normal 
limits if they were within 2 SD of mean normal values 
previously established in subjects studied al rest. 
The polar maps were divided into left anterior descending, 
circumflex and right coronary artery territories previously 
established for thallium-201 single-photon emission computed 
tomographic stizdies (20). The percent of contiguous pixels 
with values >2 SD below the mean for normal N-13 ammonia 
values WEE calculated for each of the three territories. If > 15% 
of a vasc&r territory contained contiguous pixels with N-33 
ammonia values 32 SD below normal, a flow defect was 
defined %r that vascufar territop. The > 15% threshold value 
was chrsszn to approximate the established threshold value of 
60 contigirous degrees {60c;360” = 16.6% of &umference) 
used in previous work using circomferen&l profile analyses 
rather than polar maps (21). 
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amine flow defect was evident within a vascular territory. If 
a dobutamine flow defect was evident within a vascular 
territory, a sector was defined that included only the defect. 
If the defect was small, whenever possible an additional 
region of interest was also drawn to include only the 
normally perfused myocardium in that vascular territory for 
the sake of comparison. The sectors defined on the dobut- 
an&e N-13 ammonia studies were then applied to all the 
rest and dobutamine serial N-13 ammonia images to obtain 
time-acttvity curves. An N-13 ammonia arterial input func- 
tion was generated by manually defining a small region of 
interest (25 mm’) centered in the left ventricular cavity on 
the final dynamic rest and dobutamine N-13 ammonia 
images and applying the same region of interest to all of the 
serial images. The final frame was used because of clearer 
definition of the cavity than on earlier images containing 
fewer counts. The correct position of the blood pool region 
in the left ventricular cavity was verified on each of the 
dynamic short-axis image frames. No shift of this region of 
interest from its central position was observed. 
After correcting N-13 ammonia myocardial and blood pool 
time-activity curves for physical decay of N-13 ammonia, the 
first 120 s of d,% from each defined sector were used to 
calculate myocardial blood flow using a previously validated 
two-compartment tracer kinetic model (9,lg). Nitrogen-13 
ammonia is freely diffusible into tissue and becomes trapped in 
the tissue as N-13 glutamine. The model contains a compart- 
ment for freely ditTusible M-13 ammonia in tissue, including 
vascd!ar and extravascular pools, and a second compartment 
containing the metabolically trapped nitrogen-13. No correc- 
tion is madIe for nitrogen-I3 metabolites ditlusing back into the 
first compartment. The myocardial time-activity curves were 
corrected for regional partial volume and spillover of activity 
from myocardium into the blood pool (18). Myocardial blood 
flow was determined for each defined sector on three short- 
axis planes: basal? midventricular and apical. The vahres pre- 
sented for each vascular territory *ae the average myocardial 
blood flows for the three planes. 
Coronas arteriographg. Cardiac catheterization with cor- 
onary arteriography was ordered by the patient‘s primav 
physician because of clinical signs suggesting possible signifi- 
cant coronary artery disease. Q~~r~t~tative arteriography was 
applied to the angiograms using a previously described center- 
line method (221. The arca of stenosis was compared 6th 
adj;tcent regions ef the vessel wimout significant stenosis. 
Automatic edge detection Gth manual override was used and 
a geometric method applied. Pinc;jshion distort& correciions 
were m&s. Stenosis severity is reported as ,perceat didmeter 
narrowing. 
&!SUk3 
Patient response to dobutamine. The rest and peak dobut- 
amine rate-pressure products achieved were 8,423 c 1,534 and 
18,534 I 4,052 mm Pig X beats/min. Dobutamine infusion was 
generally well tolerated. The average maximal dobutamine 
dose received was 35 t 8 pg/kg per min. Ten of the 15 patients 
received the maximal dose of 40 pL&Rrg per min (Table 1). 
Symptoms or reasons for prematurely discontinuing the dobut- 
amine infusion in the other five patients are shown in Table I. 
Nitrogen-13 ammonia was always injected before discontinua- 
tion of the dobutamine infusion. In all but two patients (one 
with nausea, one with slow ventricular tachycardia), dobut- 
amine infusion was continued for an additional 3 min after the 
N-13 ammonia injection. 
Electrocardiographic changes consistent with ischemia 
were only documented in two patients. Chest pain consistent 
with angina occurred in three other patients, only one of 
whom had signiticant coronary artery disease. Thus, these 
findings were poor predictors of significant coronary artery 
disease. 
Quantitative arteriography. Quantitative arteriography re- 
vealed that 10 of the 15 patients had a quantifiable stenosis in 
at least one coronary vessel The degree of percent diameter 
stenosis ranged from 30% to 100% (fable 2). 
Poiar map defects. Rest K-13 ammonia polar mops. Three 
patients (Patients l&12 and 13) had a total of four flow defects 
on rest imaging. All rest defects had corresponding dobut- 
amine flow defects. The average defect extent per vascular 
territory at rest was 45 + 23% and was not significantly 
dilferent from the dobutamine defect size of 59 i- 30% in these 
three patients (Table 3). Two of these patients had a history of 
a previous anterior myocardial infarction. 
Dobtctamine N-13 ammonia p&fur mnaps. Dobutamine Bow- 
defects were identified in 11 vascular territories in 8 (53%) 
of I5 patients (Table 2). Each defect was associated with a 
quantita:ed stenosis ranging from 48% to 100%. A 61% 
circumflex artery stenosis was not detected in Patient 7, u-ho 
had a very low dobutamfne rate-pressure product, Two 
patients had contiguous defects present in twc vascular 
territories that were not separated by normally ‘perfused 
myocardum. These defects represented a singIe c3roaary 
artery stenosis. A iOlY% circumflex coronary lesion pre- 
sented as a defect in the inferolaterat portion of the right 
~3rcx~ry artery distribution- All four parients with a 111evi- 
ous myocardial infarction had a dobutamine flow defezt in 
the appropriate distribution, although onIy rwo had cure- 
spondiog rest bow defects. 
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Qwntitation of myocardisl blood fbnv. To ox knowledge, 
this study is the first attempt to quantitate rnyocardial blood 
flow with N-13 ammonia jtr patknts with coroncry artery 
disease at rest and Gth dohutamine. Myocardiaf Mood flow 
and cardiac work+ as represented by the rate-pressure product, 
were closely correlated in vascular territories without defects. 
These resuks are similar ‘to those previously reported and 
similarly obtained in normaf young volunteers (25 2 G years 
old) (1). A similar correlation was also present in regions of 
interest corresponding to dobutamine flow defectsi although 
the absolute increase in defect Bows with dobutamine was 
smaller. in addition, our study has demonstrated that dobut- 
amine myocardial 610011 flow is closely correlated xvith degree 
of stenosis. Thus, doSutarnine increases tlov? in prqxkm to 
the demand bat this increase is modulated byr degree of 
stenosis present. 
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Fire 3. Absolute change in my~~~ardia! &xxi llow (XBF) divided by 
absolute rkange in rate-pressure product @UT) is plotted for each 
patierit (&g the average m~ocardial blo& flow- in myocarditlm 
without a dokursmins defect) and for cask de8xtr.d stezemsis versus rke 
measllred percent diameter stenosis. When a stenosis was not dew&ted 
for quantitation, the percent diameter stenosis was assumed to be 0% 
jcorrelation c&licient 0.65. p < &ON j. 
myocardiom and can result in decreased contractility in myo- 
cardium which becomes ischemic. Therefore? changes in aall 
motion are expected with dobutamine that were not present at 
rest. Ideally, measurement of waif thickness and thickening 
should be made for each segmzn? at rest and wi!h dobutamine 
so that cmrections Can be made for partial volume eSfects. 
Unfortucately, the means for such corrections are nut avail- 
able at thii time. Despite the lack of the;= corrections, the 
directional changes in flow measured in this study correiated 
with cardiac work and degree of stenosis. Inaccuracies in Aow 
measurements can also result because the partial vohme 
effects related to an area of thinned, infarcted myocardium are 
not appropriately estimated. 
Summary. Myoeardial Mood flow in patients with sus- 
pected coronary artery disease tincreased with dobutanrine in 
proportion to the increase in cardiac work and were inversely 
proportional to the degree of stenosis. The physiologic severity 
of the stenosis in terms of absolute flow rednction was directly 
assessed. No other noninvasive technique can accomplish this 
gtd. 
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